4th Hepatology Symposium - Autoimmune hepatitis and viral hepatitis delta

2025-09-04 16:00:002025-09-04 17:44:00Europe/Zurich4th Hepatology Symposium - Autoimmune hepatitis and viral hepatitis delta
2025-09-04 16:00:002025-09-04 17:44:00Europe/Zurich4th Hepatology Symposium - Autoimmune hepatitis and viral hepatitis delta
2025-09-04 16:00:002025-09-04 17:44:00Europe/Zurich4th Hepatology Symposium - Autoimmune hepatitis and viral hepatitis delta
2025-09-04 16:00:002025-09-04 17:44:00Europe/Zurich4th Hepatology Symposium - Autoimmune hepatitis and viral hepatitis delta

Hepatology

Insel Gruppe

Insel Gruppe

Start

04 Sep 2025 16:00

End

04 Sep 2025 17:44

Autoimmune hepatitis (AIH) and hepatitis delta (HDV) are two complex liver diseases with serious consequences for patients. While AIH is characterized by a misguided immune reaction against the body's own liver, HDV infection, the most severe form of viral hepatitis, poses a particular challenge as it only occurs in combination with a hepatitis B infection.Our event brings together leading experts to discuss the latest findings on diagnostics, disease management and innovative therapeutic approaches for these rare but serious liver diseases. Learn more about personalized treatment strategies, new drug approaches and the importance of early diagnostics for a better patient prognosis.

    CME Credits

    SGAIM : 2.00SGG : 2.00

    Speaker

    MK

    M.D. Mirjam Kolev

    PS

    Prof. Dr. rer. nat. phil. Nasser Semmo

    04 September 2025, 16:00

    04

    September

    04:00 PM

    2025

    16:00

    17:44

    4th Hepatology Symposium - Autoimmune hepatitis and viral hepatitis delta

    Autoimmune hepatitis (AIH) and hepatitis delta (HDV) are two complex liver diseases with serious consequences for patients. While AIH is characterized by a misguided immune reaction against the body's own liver, HDV infection, the most severe form of viral hepatitis, poses a particular challenge as it only occurs in combination with a hepatitis B infection.Our event brings together leading experts to discuss the latest findings on diagnostics, disease management and innovative therapeutic approaches for these rare but serious liver diseases. Learn more about personalized treatment strategies, new drug approaches and the importance of early diagnostics for a better patient prognosis.

    MK

    M.D. Mirjam Kolev

    PS

    Prof. Dr. rer. nat. phil. Nasser Semmo